Domínguez-Soto A., Aragoneses-Fenoll L., Martín-Gayo E., Martinez-Prats L., Colmenares M., Naranjo-Gómez M., Borrás F.E., Muñoz P., Zubiaur M., Toribio M.L., Delgado R., Corbi A.L. (2007): “The DC-SIGN-related lectin LSECtin mediates antigen capture and pathogen recognition on human myeloid cells”. Blood, 109: 5337-5345.

Reina J.J., Sattin S., Invernizzi D., Mari S, Martínez-Prats L., Tabarani G., Fieschi F., Delgado R., Rojo J., Bernardi A. (2007): “1,2-Mannobioside Mimic: Synthesis, DC-SIGN Interaction by NMR and Docking, and Antiviral Activity”. Chem Med Chem. 2: 1030-1036.

Jiménez-Baranda S., Gómez-Moutón C., Rojas A., Martínez-Prats L., Mira E., Ana Lacalle R., Valencia A., Dimitrov D.S., Viola A., Delgado R., Martínez-A C., Mañes S. (2007): “Filamin-A regulates actin-dependent clustering of HIV receptors”. Nature Cell Biology, 9: 838-846.

Serrano-Gómez D., Sierra-Filardi E., Martínez-Nuñez R.T., Caparrós E., Delgado R., Muñoz-Fernández M.A., Abad M.A., Jiménez-Barbero J., Leal M., Corbi A.L. (2008): “Structural requirements for multimerization of the pathogen receptor DC-sign (CD209) on the cell surface”. J Biol Chem. 283: 3889-3903.

Pulido F., Pérez-Valero I., Delgado R., Arranz A., Pasquau J., Portilla J. et al. (2009): “Risk factors for lossof virological suppression in patients receiving lopinavir/ritonavir monotherapy for maintenance of HIV suppression”. Antivir Ther. 14: 195-201.